Madhubala Manickavasagam

No ORCID on file · 2 papers in corpus
nonrandomized-trial 2025
·doi:10.18203/2320-1770.ijrcog20251562

Background: To evaluate the efficacy and tolerability of 4mg dienogest in women with adenomyosis and BMI >30. Methods: This prospective study, conducted at Lakshmi Madhavan Hospital Pvt Ltd, Tirunelveli, Tamil Nadu, between January and Octo…

observational 2024
Cureus ·doi:10.7759/cureus.72016

Background Dydrogesterone, an oral selective progesterone receptor agonist with high bioavailability, has been used since the 1960s to treat various conditions arising due to the deficiency of progesterone. Patients are expected to have add…